The expression of IL1R1 in the tumor microenvironment, the main receptor of IL1α and β, due to the interconnection with the NF-KB and MAP kinase pathways, plays contrasting roles in different tumor stages [57]. The gene discussed is NFKB1; the disease is neoplasm.